Navigation Links
Weikang Bio-technology Group, Inc. Completes HQ Relocation After Purchasing Building for $14 Million and Answers Questions About its Third Quarter Financials
Date:12/28/2011

//www.weikangbio.com/">http://www.weikangbio.com.

Contact:

Yue Kang (Venus):
+86 4-518-835-5530
+86 15846588061
Email: weikangbio@yahoo.com

Safe Harbor Statement

Certain statements in this press release constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995.  These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions, involve known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in the Company's periodic reports that are filed with the Securities and Exchange Commission and available on its website (http://www.sec.gov). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.


'/>"/>
SOURCE Weikang Bio-Technology Group Co., Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Weikang Bio-Technology to Present at Rodman & Renshaw Annual China Investment Conference
2. Weikang Bio-Technology Announces Inclusion of Ranitidine Hydrochloride Capsule on National Drug Reimbursement List
3. Weikang Bio-Technology Expects to Report Fiscal 2010 Revenue of $77.8 Million and Net Income of $31.2 Million or $1.04 Earnings per Share
4. Weikang Bio-Technology Plans to Launch New Therapeutics in First Quarter 2011
5. Weikang Bio-Technology to Present at Global Hunter 2010 China Conference on July 13, 2010
6. Weikang Bio-Technology Announces Filing for NASDAQ Listing
7. Weikang Bio-Technology Reports First Quarter 2010 Financial Results
8. Unity Management Group, Inc. Announces Its Initial Sale of the PZ UNO Tablet Press to a Major Pharmaceutical Company for $500,000
9. Unity Management Group, Inc. Receives Contract From Sun Pharmaceutical Indias Largest Pharmaceutical Companies for $105,000
10. Global Pharm Holdings Group, Inc. Announces Third Quarter 2011 Financial Results
11. Global Pharm Holdings Group, Inc. Completes Acquisition of Qingdao Likang Pharmaceutical Co., Ltd.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... MELVILLE, N.Y., July 29, 2015  Henry Schein, ... provider of health care products and services to ... reported record second quarter financial results. ... 2015 were $2.6 billion, an increase of 0.5% ... consisted of 7.5% growth in local currencies and ...
(Date:7/29/2015)... VIEW, Calif. , July 29, 2015  Efforts ... the growth strategy of pharmaceutical firms in ... . The realization is that an effective working capital ... pricing pressures and patent cliffs. Big pharma companies expect ... returns. Logo - http://photos.prnewswire.com/prnh/20150724/241957LOGO ...
(Date:7/28/2015)... , July 28, 2015 Codman Neuro*, ... has introduced a new platform of embolic coils for ... detachment system designed to improve microcatheter stability and provide ... announcement was made here at the Society of NeuroInterventional ... The family of framing, filling and finishing coils used ...
Breaking Medicine Technology:Henry Schein Reports Record Second Quarter Results 2Henry Schein Reports Record Second Quarter Results 3Henry Schein Reports Record Second Quarter Results 4Henry Schein Reports Record Second Quarter Results 5Henry Schein Reports Record Second Quarter Results 6Henry Schein Reports Record Second Quarter Results 7Henry Schein Reports Record Second Quarter Results 8Henry Schein Reports Record Second Quarter Results 9Henry Schein Reports Record Second Quarter Results 10Henry Schein Reports Record Second Quarter Results 11Henry Schein Reports Record Second Quarter Results 12Henry Schein Reports Record Second Quarter Results 13Henry Schein Reports Record Second Quarter Results 14Henry Schein Reports Record Second Quarter Results 15Henry Schein Reports Record Second Quarter Results 16Henry Schein Reports Record Second Quarter Results 17Henry Schein Reports Record Second Quarter Results 18Henry Schein Reports Record Second Quarter Results 19Henry Schein Reports Record Second Quarter Results 20Henry Schein Reports Record Second Quarter Results 21Henry Schein Reports Record Second Quarter Results 22Henry Schein Reports Record Second Quarter Results 23Henry Schein Reports Record Second Quarter Results 24Henry Schein Reports Record Second Quarter Results 25Working Capital Management Seizes Priority in North American and European Pharma Industry 2Working Capital Management Seizes Priority in North American and European Pharma Industry 3Working Capital Management Seizes Priority in North American and European Pharma Industry 4Codman Neuro Launches Family Of Coils For Treatment Of Brain Aneurysms 2Codman Neuro Launches Family Of Coils For Treatment Of Brain Aneurysms 3Codman Neuro Launches Family Of Coils For Treatment Of Brain Aneurysms 4
... Mass., July 28, 2011 Boston Scientific Corporation (NYSE: ... ended June 30, 2011, as well as net sales and ... updated guidance for the full year 2011.  The Company exceeded ... EPS guidance for the remainder of the year. ...
... July 28, 2011 Streamline Health Solutions, Inc. (Nasdaq: ... document workflow solutions for hospitals, announced today that two ... health system in North Carolina, contracted with Streamline Health ... Health Resources, which began the beta phase of integration ...
Cached Medicine Technology:Boston Scientific Second Quarter Results Exceed Consensus Sales and EPS; Full-Year Guidance Raised 2Boston Scientific Second Quarter Results Exceed Consensus Sales and EPS; Full-Year Guidance Raised 3Boston Scientific Second Quarter Results Exceed Consensus Sales and EPS; Full-Year Guidance Raised 4Boston Scientific Second Quarter Results Exceed Consensus Sales and EPS; Full-Year Guidance Raised 5Boston Scientific Second Quarter Results Exceed Consensus Sales and EPS; Full-Year Guidance Raised 6Boston Scientific Second Quarter Results Exceed Consensus Sales and EPS; Full-Year Guidance Raised 7Boston Scientific Second Quarter Results Exceed Consensus Sales and EPS; Full-Year Guidance Raised 8Boston Scientific Second Quarter Results Exceed Consensus Sales and EPS; Full-Year Guidance Raised 9Boston Scientific Second Quarter Results Exceed Consensus Sales and EPS; Full-Year Guidance Raised 10Boston Scientific Second Quarter Results Exceed Consensus Sales and EPS; Full-Year Guidance Raised 11Boston Scientific Second Quarter Results Exceed Consensus Sales and EPS; Full-Year Guidance Raised 12Boston Scientific Second Quarter Results Exceed Consensus Sales and EPS; Full-Year Guidance Raised 13Boston Scientific Second Quarter Results Exceed Consensus Sales and EPS; Full-Year Guidance Raised 14Boston Scientific Second Quarter Results Exceed Consensus Sales and EPS; Full-Year Guidance Raised 15Boston Scientific Second Quarter Results Exceed Consensus Sales and EPS; Full-Year Guidance Raised 16Boston Scientific Second Quarter Results Exceed Consensus Sales and EPS; Full-Year Guidance Raised 17Boston Scientific Second Quarter Results Exceed Consensus Sales and EPS; Full-Year Guidance Raised 18Boston Scientific Second Quarter Results Exceed Consensus Sales and EPS; Full-Year Guidance Raised 19Boston Scientific Second Quarter Results Exceed Consensus Sales and EPS; Full-Year Guidance Raised 20Boston Scientific Second Quarter Results Exceed Consensus Sales and EPS; Full-Year Guidance Raised 21Boston Scientific Second Quarter Results Exceed Consensus Sales and EPS; Full-Year Guidance Raised 22Boston Scientific Second Quarter Results Exceed Consensus Sales and EPS; Full-Year Guidance Raised 23Streamline Health Announces Two Clients Have Contracted for Multiple Integrations to Their Epic Systems 2Streamline Health Announces Two Clients Have Contracted for Multiple Integrations to Their Epic Systems 3Streamline Health Announces Two Clients Have Contracted for Multiple Integrations to Their Epic Systems 4
(Date:7/29/2015)... ... 29, 2015 , ... Zofran lawsuits around the nation are ... (JPML), according to court documents.* Attorneys handling Zofran lawsuits provide timely ... Lawsuit Center. , GlaxoSmithKline, the global pharmaceutical conglomerate and defendant in national Zofran ...
(Date:7/29/2015)... ... , ... The New Foundation AZ recently started a massive renovation ... the 501(c) organization nearly $1 million, will both update the facilities’ design and fixtures ... down to the studs,” said Geraldine Leary, the New Foundation AZ chief executive officer. ...
(Date:7/29/2015)... ... July 29, 2015 , ... The Woodlands and Spring Fit Body Boot Camps ... worthy charitable causes each month. The new system will track each time a client ... In at each facility, the boot camps will donate 20 cents to a selected ...
(Date:7/29/2015)... ... July 29, 2015 , ... HealthPostures ( https://healthpostures.com ), a ... 247Ergo, an ergonomics specialty firm. Purpose of the partnership is to help strengthen ... could improve worker mobility, functionality and fitness levels. , Executives at HealthPostures ...
(Date:7/29/2015)... , ... July 29, 2015 , ... Indiana is known ... is also the home of Zerorez Indianapolis, which plans to expand across the state. ... “2015 is our second full year in business and we should double our first ...
Breaking Medicine News(10 mins):Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 2Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 3Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 4Health News:The New Foundation AZ Renovates Residential Dorms for Youth in Crisis 2Health News:The New Foundation AZ Renovates Residential Dorms for Youth in Crisis 3Health News:Transforming Texan Lives and Bodies: Woodlands and Spring Fitness Boot Camps Commit to Multiple Charity Donations 2Health News:Transforming Texan Lives and Bodies: Woodlands and Spring Fitness Boot Camps Commit to Multiple Charity Donations 3Health News:HealthPostures and 247Ergo Partnership Strengthens America's Wellness 2Health News:HealthPostures and 247Ergo Partnership Strengthens America's Wellness 3Health News:Zerorez® Announces Plans to Roll Across Indiana—“The Crossroads of America.” 2Health News:Zerorez® Announces Plans to Roll Across Indiana—“The Crossroads of America.” 3
... and coordinating a European FP7 research project for SMEs, ... products with lower concentrations of biocides and, thereby, be ... The two years lasting project will be carried out ... and five SME companies: Berkem (France), Linotech (Sweden), Rutlandbio ...
... Mo. -- For some women, the effects of breast cancer, ... they leave the hospital. Now, researchers in the University of ... breast cancer patients following chemotherapy and found that their environments ... lives. "A lot of times people get mentally ...
... By Steven Reinberg HealthDay Reporter , WEDNESDAY, Oct. ... food allergies may be increased if that child is conceived ... suggests. Studies have already shown that children born in ... asthma than children born in spring or summer, the researchers ...
... , WEDNESDAY, Oct. 20 (HealthDay News) -- People with ... potentially serious eye damage, says a small new study from ... is located near the center of the retina at the ... central vision and the processing of light. In this ...
... TUESDAY, Oct. 19 (HealthDay News) -- A new ... secondhand: Too much alcohol slows reaction time and increases ... alcohol affects certain brain regions involved in error processing ... who received no alcohol (control group) or different doses ...
... . In a world first, a completely ... McGill University Health Centre (MUHC). The DaVinci surgical robot, ... to work this summer, whereas the anesthesia robot, nicknamed ... two combined to perform the first all-robotic surgery on ...
Cached Medicine News:Health News:Tecnalia develops environment-friendly and health-friendly pest control products 2Health News:Women fight the effects of chemotherapy long after treatment ends 2Health News:Pregnancy During Spring May Boost Kid's Risk of Food Allergies 2Health News:People With Anorexia May Risk Serious Eye Damage 2Health News:McSleepy meets DaVinci 2
The Micro-Temp® II safely and consistently delivers a therapeutic level of localized heat using a pump, connecting hose and localized temperature therapy pad....
The Osom® Bvblue Test detects elevated vaginal fluid sialidase activity, an enzyme produced by bacterial pathogens associated with Bacterial Vaginosis including Gardnerella, Bacteroides, Prevote...
Flat Wire Stone Basket...
Nitinol Flat Wire Basket...
Medicine Products: